MẌ Orthopedics Receives FDA Clearance on the dynaMẌ™ Nitinol Compression Screw (press release)
LEXINGTON, Mass., June 7, 2016 /PRNewswire/ -- MẌ Orthopedics, Corp. (MẌO), an orthopedic implant company focused on improving implant/bone fixation, is proud to announce the recent FDA clearance (K160427) of the dynaMẌ™ Nitinol Compression Screw. The dynaMẌ™ Nitinol Compression Screw utilizes the superelastic properties of Nitinol to provide higher levels of compression than contemporary bone screws. During manufacturing, the dynaMẌ™ Nitinol Compression Screw is stretched and held in an elongated position with an internal pin. Following implantation, the internal pin is removed and the Screw attempts to shorten and return to its original unstretched length, thereby providing desirable compression.
"Bone is a living material that remodels with altering stress levels, changing shape and mechanical properties. The dynamic healing process of bone warrants a dynamic implant material. The dynaMẌ™ Nitinol Compression Screw represents the next generation of screw fixation technology as it is engineered to change shape in vivo, enhancing fracture reduction while applying controlled ...
Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !

